Markets

Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today reported its financial and business results for the second quarter ended June 30,…

Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced a conference call and webcast to discuss topline results from the Phase…

Dejero, ADLINK Technology, Eutelsat and Intel among the sponsors powering the first-ever livestream of North America's only tarmac rally, with a live demonstration at IBC and a video message from…

Gleklen, who invests in AI-application companies, joins new principal Jason Mendel and eight other investors globally promoted to new roles

Strategic acquisitions, expanded credit facilities, and strong segment performance position Algoma for continued growth.

Sia continues its international expansion with the acquisition of Seven Consulting, an Australian management consulting firm known for its expertise in Business Transformation, serving many of the country’s largest Banking,…

2Q 2026This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806509750/en/ Total business volume at 45.6 billion euros, an internal growth of 5.7 percent1, with contributions from all segments.…

Net cash used in operating and investing activities was $25.7 million in the second quarter and net cash provided by operating and investing activities was $3.2 million for the first…

The product leader who helped scale Datadog from early-stage startup through IPO brings deep product expertise to Vercel's board

New AEO Visibility Dashboard gives brand marketers a clear view of how AI assistants are citing, mentioning, and ranking them